A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study
Main Authors: | Maryam Tavakoli Chaleshtori, Ziba Farajzadegan, Mansour Salesi |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2022-04-01
|
Series: | European Journal of Rheumatology |
Online Access: | https://www.eurjrheumatol.org/en/a-comparison-of-rituximab-with-cyclophosphamide-in-terms-of-efficacy-and-complications-as-induction-therapy-for-treating-granulomatosis-with-polyangiitis-a-three-center-study-133461 |
Similar Items
-
Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
by: M. Benucci, et al.
Published: (2013-05-01) -
Unexpected positive effects of rituximab and corticosteroids on COVID-19 in a patient suffering from granulomatosis with polyangiitis
by: Mansour Salesi, et al.
Published: (2021-01-01) -
Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
by: Shah S, et al.
Published: (2015-08-01) -
Activation of natural killer cells by rituximab in granulomatosis with polyangiitis
by: Doris Urlaub, et al.
Published: (2019-12-01) -
Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)
by: Uchida, L, et al.
Published: (2024)